Differential regulation of steroidogenic enzymes metabolizing testosterone or dihydrotestosterone by human chorionic gonadotropin in cultured rat neonatal interstitial cells.
The present studies examined the effects of hCG on steroidogenic enzyme activities involved in the metabolism of testosterone or dihydrostestosterone in cultured rat neonatal interstitial cells. 5 alpha-reductase and 17 beta-hydroxysteroid dehydrogenase activities, which are involved in the conversion of testosterone to dihydrotestosterone and androstenedione, respectively, were low in cultured neonatal interstitial cells, were unresponsive to hCG and declined to undetectable levels during 14 days of culture. However, delta 5-3 beta-hydroxysteroid dehydrogenase-isomerase activity, which is involved in the biosynthesis of testosterone, and 5 alpha-androstane-3 alpha-hydroxysteroid dehydrogenase and 5 alpha-androstane-3 beta-hydroxysteroid dehydrogenase activities, which are involved in the conversion of dihydrotestosterone to 5 alpha-androstan-3 alpha, 17 beta-diol and 5 alpha-androstan-3 beta, 17 beta-diol, respectively, were maintained or increased by hCG during the same culture period. These results demonstrate that 5 alpha-reductase and 17 beta-hydroxysteroid dehydrogenase activities do not play a significant role in regulating testosterone accumulation in fetal/neonatal Leydig cells, and they suggest that these cells are adapted to maintain high testosterone but low dihydrotestosterone levels. The present results demonstrate also that fetal/neonatal Leydig cells differ from immature or adult Leydig cells with respect to the sensitivity of 5 alpha-reductase activity to LH/hCG.
Murono
E P
EP
Research Service, Dorn Veteran's Hospital, Columbia, South Carolina.
D015067:17-Hydroxysteroid Dehydrogenases / Q000378:metabolism; D015096:3-Hydroxysteroid Dehydrogenases / Q000378:metabolism; D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase / Q000378:metabolism; D058891:5-alpha Reductase Inhibitors; D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism*; D001378:Azasteroids; D002478:Cells, Cultured; D006063:Chorionic Gonadotropin / Q000494:pharmacology*; D013196:Dihydrotestosterone / Q000378:metabolism*; D007985:Leydig Cells / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D011278:Pregnanes / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013739:Testosterone / Q000378:metabolism*
D058891:5-alpha Reductase Inhibitors; D001378:Azasteroids; D006063:Chorionic Gonadotropin; D011278:Pregnanes; D013196:Dihydrotestosterone; D013739:Testosterone; C037399:4-methyl-4-aza-3-oxopregnane-20-carboxylate; D015067:17-Hydroxysteroid Dehydrogenases; D015096:3-Hydroxysteroid Dehydrogenases; C063640:5alpha-androstane-3alpha-hydroxysteroid dehydrogenase; C063641:5alpha-androstane-3beta-hydroxysteroid dehydrogenase; C032690:3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+)); D013741:3-Oxo-5-alpha-Steroid 4-Dehydrogenase